June 2, 2023
CHICAGO – Sunscreen recommendations are most effective when a multitude of factors are considered, Susan C. Taylor, MD, said during a presentation on personal photoprotection at the inaugural […]
June 2, 2023
A team of researchers has identified genomic variants that cause disabling pansclerotic morphea (DPM), a rare, severe inflammatory skin disorder, and report that the Janus kinase (JAK) […]
June 1, 2023
The European Commission has approved secukinumab (Cosentyx) as a treatment for adults with active, moderate to severe hidradenitis suppurativa (HS) that didn’t respond to conventional therapy. […]
May 31, 2023
Around 5% of patients treated with dupilumab (Dupixent) for moderate-to-severe atopic dermatitis experience musculoskeletal (MSK) symptoms, according to the results of a descriptive study. The main […]
May 30, 2023
WASHINGTON – Abrocitinib demonstrated an acceptable long-term safety profile in adolescents with moderate to severe atopic dermatitis (AD) in an integrated safety analysis of 635 adolescents and over […]
May 25, 2023
WASHINGTON — Atopic dermatitis (AD) in childhood presents most commonly by age 1 and typically begins on the face, and while it can make infants “miserable,” caregiver and […]
May 22, 2023
Adding online mindfulness and self-compassion training to usual care may improve quality of life (QOL) in adults with atopic dermatitis (AD), according to results of a […]
May 19, 2023
The US Food and Drug Administration (FDA) has approved the first-ever topical gene therapy, which will be used to treat wounds in patients 6 months of […]
May 18, 2023
A distinct gene expression was identified in T2a cutaneous squamous cell carcinoma (cSCC) associated with poor outcomes, according to new findings. Researchers found that 12 genes […]